141 related articles for article (PubMed ID: 10224044)
1. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins.
Yanagi Y; Suzawa M; Kawabata M; Miyazono K; Yanagisawa J; Kato S
J Biol Chem; 1999 May; 274(19):12971-4. PubMed ID: 10224044
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements.
Subramaniam N; Leong GM; Cock TA; Flanagan JL; Fong C; Eisman JA; Kouzmenko AP
J Biol Chem; 2001 May; 276(19):15741-6. PubMed ID: 11278818
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
4. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.
Yanagisawa J; Yanagi Y; Masuhiro Y; Suzawa M; Watanabe M; Kashiwagi K; Toriyabe T; Kawabata M; Miyazono K; Kato S
Science; 1999 Feb; 283(5406):1317-21. PubMed ID: 10037600
[TBL] [Abstract][Full Text] [Related]
5. 1,25-(OH(2))D(3) alters the transforming growth factor beta signaling pathway in renal tissue.
Aschenbrenner JK; Sollinger HW; Becker BN; Hullett DA
J Surg Res; 2001 Oct; 100(2):171-5. PubMed ID: 11592788
[TBL] [Abstract][Full Text] [Related]
6. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
8. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
Datta PK; Moses HL
Mol Cell Biol; 2000 May; 20(9):3157-67. PubMed ID: 10757800
[TBL] [Abstract][Full Text] [Related]
9. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
10. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.
Choy L; Skillington J; Derynck R
J Cell Biol; 2000 May; 149(3):667-82. PubMed ID: 10791980
[TBL] [Abstract][Full Text] [Related]
11. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
12. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
Takagawa S; Lakos G; Mori Y; Yamamoto T; Nishioka K; Varga J
J Invest Dermatol; 2003 Jul; 121(1):41-50. PubMed ID: 12839562
[TBL] [Abstract][Full Text] [Related]
14. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
15. Deficient Smad7 expression: a putative molecular defect in scleroderma.
Dong C; Zhu S; Wang T; Yoon W; Li Z; Alvarez RJ; ten Dijke P; White B; Wigley FM; Goldschmidt-Clermont PJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3908-13. PubMed ID: 11904440
[TBL] [Abstract][Full Text] [Related]
16. Smad7 and Smad6 differentially modulate transforming growth factor beta -induced inhibition of embryonic lung morphogenesis.
Zhao J; Shi W; Chen H; Warburton D
J Biol Chem; 2000 Aug; 275(31):23992-7. PubMed ID: 10801843
[TBL] [Abstract][Full Text] [Related]
17. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]